HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults: Projection Based on the CSPPT.

Abstract
The CSPPT (China Stroke Primary Prevention Trial) demonstrated a significant risk reduction of first stroke in hypertensive patients treated with enalapril plus folic acid compared with those with enalapril alone, but the lifetime stroke-free survival associated with the treatment is unknown. By establishing adjusted models for competing risks and an age-based time scale using data from 19 053 participants of the CSPPT, we estimated lifetime incremental stroke-free survival for enalapril-folic acid versus enalapril alone. Compared with enalapril alone, the enalapril plus folic acid treatment projected a mean lifetime stroke-free survival gain of 1.75 months, with an interquartile range from 0.73 to 2.39 months and the maximum gain up to 12.95 months. Subgroup analyses showed greater gain in stroke-free survival in younger, male patients, those with lower baseline folate levels, higher baseline systolic blood pressure, higher baseline total cholesterol and blood glucose, and with MTHFR (methylenetetrahydrofolate reductase) C677T CT or TT genotype. Overall, besides significant benefit in certain subgroups, enalapril plus folic acid treatment for hypertensive patients is associated with a modest gain in lifetime stroke-free survival, compared with enalapril alone.
AuthorsTiantian Zhang, Tengfei Lin, Yang Wang, Binyan Wang, Xianhui Qin, Feng Xie, Yimin Cui, Yong Huo, Xiaobin Wang, Zugui Zhang, Jie Jiang
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 75 Issue 2 Pg. 339-346 (02 2020) ISSN: 1524-4563 [Electronic] United States
PMID31865785 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Vitamin B Complex
  • Folic Acid
Topics
  • Aged
  • Blood Pressure (physiology)
  • Disease-Free Survival
  • Double-Blind Method
  • Female
  • Folic Acid (administration & dosage)
  • Follow-Up Studies
  • Humans
  • Hypertension (complications, drug therapy, physiopathology)
  • Male
  • Middle Aged
  • Primary Prevention (methods)
  • Stroke (etiology, prevention & control)
  • Treatment Outcome
  • Vitamin B Complex (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: